These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 24508032)
1. Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Vivas-Consuelo D; Usó-Talamantes R; Trillo-Mata JL; Caballer-Tarazona M; Barrachina-Martínez I; Buigues-Pastor L Health Policy; 2014 Jun; 116(2-3):188-95. PubMed ID: 24508032 [TBL] [Abstract][Full Text] [Related]
2. Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions. Vivas D; Guadalajara N; Barrachina I; Trillo JL; Usó R; de-la-Poza E Health Policy; 2011 Nov; 103(1):9-15. PubMed ID: 21956046 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. Vivas-Consuelo D; Usó-Talamantes R; Guadalajara-Olmeda N; Trillo-Mata JL; Sancho-Mestre C; Buigues-Pastor L BMC Health Serv Res; 2014 Oct; 14():462. PubMed ID: 25331531 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models. Stam PJ; van Vliet RC; van de Ven WP Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368 [TBL] [Abstract][Full Text] [Related]
5. Obtaining the mean relative weights of the cost of care in Catalonia (Spain): retrospective application of the adjusted clinical groups case-mix system in primary health care. Sicras-Mainar A; Velasco-Velasco S; Navarro-Artieda R; Aguado Jodar A; Plana-Ripoll O; Hermosilla-Pérez E; Bolibar-Ribas B; Prados-Torres A; Violan-Fors C J Eval Clin Pract; 2013 Apr; 19(2):267-76. PubMed ID: 22458780 [TBL] [Abstract][Full Text] [Related]
6. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Lamers LM; van Vliet RC Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558 [TBL] [Abstract][Full Text] [Related]
7. [Impact of cardiovascular risk factors on the consumption of resources in Primary Care according to Clinical Risk Groups]. Millá Perseguer M; Guadalajara Olmeda N; Vivas Consuelo D Aten Primaria; 2019 Apr; 51(4):218-229. PubMed ID: 29908781 [TBL] [Abstract][Full Text] [Related]
8. The importance of comorbidity in analysing patient costs in Swedish primary care. Engström SG; Carlsson L; Ostgren CJ; Nilsson GH; Borgquist LA BMC Public Health; 2006 Feb; 6():36. PubMed ID: 16483369 [TBL] [Abstract][Full Text] [Related]
9. Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada. Hanley GE; Morgan S; Reid RJ Med Care; 2010 May; 48(5):402-8. PubMed ID: 20393369 [TBL] [Abstract][Full Text] [Related]
10. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841 [TBL] [Abstract][Full Text] [Related]
11. Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example. Huang IC; Dominici F; Frangakis C; Diette GB; Damberg CL; Wu AW Med Decis Making; 2005; 25(1):20-34. PubMed ID: 15673579 [TBL] [Abstract][Full Text] [Related]
12. Comparing self-reported health status and diagnosis-based risk adjustment to predict 1- and 2 to 5-year mortality. Pietz K; Petersen LA Health Serv Res; 2007 Apr; 42(2):629-43. PubMed ID: 17362210 [TBL] [Abstract][Full Text] [Related]
13. Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Hughes JS; Averill RF; Eisenhandler J; Goldfield NI; Muldoon J; Neff JM; Gay JC Med Care; 2004 Jan; 42(1):81-90. PubMed ID: 14713742 [TBL] [Abstract][Full Text] [Related]
14. The London low emission zone baseline study. Kelly F; Armstrong B; Atkinson R; Anderson HR; Barratt B; Beevers S; Cook D; Green D; Derwent D; Mudway I; Wilkinson P; Res Rep Health Eff Inst; 2011 Nov; (163):3-79. PubMed ID: 22315924 [TBL] [Abstract][Full Text] [Related]
15. Risk adjustment and primary health care in Chile. Vargas V; Wasem J Croat Med J; 2006 Jun; 47(3):459-68. PubMed ID: 16758525 [TBL] [Abstract][Full Text] [Related]
16. Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithm. Kuo RN; Dong YH; Liu JP; Chang CH; Shau WY; Lai MS Med Care; 2011 Nov; 49(11):1031-9. PubMed ID: 21945973 [TBL] [Abstract][Full Text] [Related]
17. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs. Lamers LM Med Care; 1999 Aug; 37(8):824-30. PubMed ID: 10448725 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the equity of age-sex adjusted primary care capitation payments in Ontario, Canada. Sibley LM; Glazier RH Health Policy; 2012 Feb; 104(2):186-92. PubMed ID: 22078665 [TBL] [Abstract][Full Text] [Related]
19. [Pharmaceutical expenditure in primary care according to the prescription source]. Lomeña Villalobos JA; Ceballos Vacas M; Medina Arteaga MT; Mediavilla Cordero E; Sarmiento Jiménez F; Hernández Grande JL Aten Primaria; 1996 Jun; 18(1):35-8. PubMed ID: 8768540 [TBL] [Abstract][Full Text] [Related]
20. Predicting healthcare expenditure by multimorbidity groups. Caballer-Tarazona V; Guadalajara-Olmeda N; Vivas-Consuelo D Health Policy; 2019 Apr; 123(4):427-434. PubMed ID: 30791988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]